View in EDS

Assessing Patient Risk, Benefit, and Outcomes in Drug Development: A Decade of Dabrafenib and Trametinib Clinical Trials.

Saved in:
Bibliographic Details
Title: Assessing Patient Risk, Benefit, and Outcomes in Drug Development: A Decade of Dabrafenib and Trametinib Clinical Trials.
Authors: Jhanji V; Office of Medical Student Research, Oklahoma State University Center for Health Sciences, Tulsa, Oklahoma., Duncan J; Office of Medical Student Research, Oklahoma State University Center for Health Sciences, Tulsa, Oklahoma., Gardner T; Office of Medical Student Research, Oklahoma State University Center for Health Sciences, Tulsa, Oklahoma., Hughes GK; Office of Medical Student Research, Oklahoma State University Center for Health Sciences, Tulsa, Oklahoma., McIntire R; Office of Medical Student Research, Oklahoma State University Center for Health Sciences, Tulsa, Oklahoma., Peña AM; Office of Medical Student Research, Oklahoma State University Center for Health Sciences, Tulsa, Oklahoma., Ladd C; Office of Medical Student Research, Oklahoma State University Center for Health Sciences, Tulsa, Oklahoma., Gardner B; Office of Medical Student Research, Oklahoma State University Center for Health Sciences, Tulsa, Oklahoma., Moore T; Office of Medical Student Research, Oklahoma State University Center for Health Sciences, Tulsa, Oklahoma., Garrett E; Office of Medical Student Research, Oklahoma State University Center for Health Sciences, Tulsa, Oklahoma., Cook C; Department of Dermatology, University of Oklahoma Medical Center, Oklahoma City, Oklahoma., Haslam A; Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California., Prasad VK; Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California., Vassar M; Office of Medical Student Research, Oklahoma State University Center for Health Sciences, Tulsa, Oklahoma.; Department of Psychiatry and Behavioral Sciences, Oklahoma State University Center for Health Sciences, Tulsa, Oklahoma.
Source: Molecular cancer therapeutics [Mol Cancer Ther] 2025 Nov 03; Vol. 24 (11), pp. 1701-1711.
Publication Type: Journal Article
Journal Info: Publisher: American Association for Cancer Research, Inc Country of Publication: United States NLM ID: 101132535 Publication Model: Print Cited Medium: Internet ISSN: 1538-8514 (Electronic) Linking ISSN: 15357163 NLM ISO Abbreviation: Mol Cancer Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40638518
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Assessing Patient Risk, Benefit, and Outcomes in Drug Development: A Decade of Dabrafenib and Trametinib Clinical Trials.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Jhanji+V%22">Jhanji V</searchLink>; Office of Medical Student Research, Oklahoma State University Center for Health Sciences, Tulsa, Oklahoma.<br /><searchLink fieldCode="AU" term="%22Duncan+J%22">Duncan J</searchLink>; Office of Medical Student Research, Oklahoma State University Center for Health Sciences, Tulsa, Oklahoma.<br /><searchLink fieldCode="AU" term="%22Gardner+T%22">Gardner T</searchLink>; Office of Medical Student Research, Oklahoma State University Center for Health Sciences, Tulsa, Oklahoma.<br /><searchLink fieldCode="AU" term="%22Hughes+GK%22">Hughes GK</searchLink>; Office of Medical Student Research, Oklahoma State University Center for Health Sciences, Tulsa, Oklahoma.<br /><searchLink fieldCode="AU" term="%22McIntire+R%22">McIntire R</searchLink>; Office of Medical Student Research, Oklahoma State University Center for Health Sciences, Tulsa, Oklahoma.<br /><searchLink fieldCode="AU" term="%22Peña+AM%22">Peña AM</searchLink>; Office of Medical Student Research, Oklahoma State University Center for Health Sciences, Tulsa, Oklahoma.<br /><searchLink fieldCode="AU" term="%22Ladd+C%22">Ladd C</searchLink>; Office of Medical Student Research, Oklahoma State University Center for Health Sciences, Tulsa, Oklahoma.<br /><searchLink fieldCode="AU" term="%22Gardner+B%22">Gardner B</searchLink>; Office of Medical Student Research, Oklahoma State University Center for Health Sciences, Tulsa, Oklahoma.<br /><searchLink fieldCode="AU" term="%22Moore+T%22">Moore T</searchLink>; Office of Medical Student Research, Oklahoma State University Center for Health Sciences, Tulsa, Oklahoma.<br /><searchLink fieldCode="AU" term="%22Garrett+E%22">Garrett E</searchLink>; Office of Medical Student Research, Oklahoma State University Center for Health Sciences, Tulsa, Oklahoma.<br /><searchLink fieldCode="AU" term="%22Cook+C%22">Cook C</searchLink>; Department of Dermatology, University of Oklahoma Medical Center, Oklahoma City, Oklahoma.<br /><searchLink fieldCode="AU" term="%22Haslam+A%22">Haslam A</searchLink>; Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California.<br /><searchLink fieldCode="AU" term="%22Prasad+VK%22">Prasad VK</searchLink>; Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California.<br /><searchLink fieldCode="AU" term="%22Vassar+M%22">Vassar M</searchLink>; Office of Medical Student Research, Oklahoma State University Center for Health Sciences, Tulsa, Oklahoma.; Department of Psychiatry and Behavioral Sciences, Oklahoma State University Center for Health Sciences, Tulsa, Oklahoma.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101132535%22">Molecular cancer therapeutics</searchLink> [Mol Cancer Ther] 2025 Nov 03; Vol. 24 (11), pp. 1701-1711.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Association+for+Cancer+Research%2C+Inc%22">American Association for Cancer Research, Inc </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101132535 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1538-8514 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215357163%22">15357163 </searchLink><i>NLM ISO Abbreviation: </i>Mol Cancer Ther <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40638518
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1158/1535-7163.MCT-23-0805
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1701
    Titles:
      – TitleFull: Assessing Patient Risk, Benefit, and Outcomes in Drug Development: A Decade of Dabrafenib and Trametinib Clinical Trials.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Jhanji V
      – PersonEntity:
          Name:
            NameFull: Duncan J
      – PersonEntity:
          Name:
            NameFull: Gardner T
      – PersonEntity:
          Name:
            NameFull: Hughes GK
      – PersonEntity:
          Name:
            NameFull: McIntire R
      – PersonEntity:
          Name:
            NameFull: Peña AM
      – PersonEntity:
          Name:
            NameFull: Ladd C
      – PersonEntity:
          Name:
            NameFull: Gardner B
      – PersonEntity:
          Name:
            NameFull: Moore T
      – PersonEntity:
          Name:
            NameFull: Garrett E
      – PersonEntity:
          Name:
            NameFull: Cook C
      – PersonEntity:
          Name:
            NameFull: Haslam A
      – PersonEntity:
          Name:
            NameFull: Prasad VK
      – PersonEntity:
          Name:
            NameFull: Vassar M
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 03
              M: 11
              Text: 2025 Nov 03
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1538-8514
          Numbering:
            – Type: volume
              Value: 24
            – Type: issue
              Value: 11
          Titles:
            – TitleFull: Molecular cancer therapeutics
              Type: main
ResultId 1